[1]Falck-Ytter Y, Francis CW, Johanson NA, et al. Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Chest.2012;141(2 Suppl):e278S-325S.[2]Geerts WH, Pineo GF, Heit JA, et al.Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.Chest.2004;126(3 Suppl):338S-400S. [3]Geerts WH, Heit JA, Clagett GP, et al.Prevention of venous thromboembolism.Chest. 2001;119(1 Suppl):132S-175S.[4]Heit JA, O'Fallon WM, Petterson TM, et al.Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study.Arch Intern Med.2002; 162(11):1245-1248.[5]Anderson FA Jr, Spencer FA.Risk factors for venous thromboembolism.Circulation.2003;107(23 Suppl 1):I9-16.[6]Swayze OS, Nasser S, Roberson JR.Deep venous thrombosis in total hip arthroplasty.Orthop Clin North Am. 1992;23(2):359-364. [7]Stulberg BN, Insall JN, Williams GW, et al.Deep-vein thrombosis following total knee replacement. An analysis of six hundred and thirty-eight arthroplasties.J Bone Joint Surg Am.1984;66(2):194-201.[8]吕厚山.人工关节外科学[M].北京:科学出版社,2001:184-189.[9]杨刚,吕厚山,高健,等.低分子肝素预防人工髋、膝关节置换术后下肢深静脉血栓形成的研究[J].中华外科杂志,2000,38(1): 25-27.[10]袁加斌,刘仲前.下肢手术后症状的下肢深静脉血栓形成[J].中国矫形外科杂志,2001,8(4):355-357.[11]Fong YK, Ruban P, Yeo SJ, et al.Use of low molecular weight heparin for prevention of deep vein thrombosis in total knee arthroplasty--a study of its efficacy in an Asian population.Ann Acad Med Singapore.2000;29(4):439-441.[12]Lotke PA.The role of aspirin for thromboembolic disease in total joint arthroplasty.Am J Knee Surg.1999;12(1):61-63.[13]Cizza G, Primma S, Csako G.Depression as a risk factor for osteoporosis.Trends Endocrinol Metab.2009;20(8):367-373.[14]Williams LJ, Bjerkeset O, Langhammer A, et al.The association between depressive and anxiety symptoms and bone mineral density in the general population: the HUNT Study.J Affect Disord.2011;131(1-3):164-171.[15]中国知网.中国学术期刊总库[DB/OL].2013-1-12. https://www.cnki.net[16]万方数据库.万方数据知识服务平台[DB/OL].2013-1-12. http://www.wanfangdata.com.cn[17]赵涵正,高书图.益气活血法预防全髋关节置换术后下肢深静脉血栓形成的临床研究[J].中医临床研究,2012,4(23):79-80. [18]金翔,张允申,陈金飞,等.活血通络汤预防人工股骨头置换后下肢深静脉血栓形成[J].中国组织工程研究与临床康复,2010,14(26): 4787-4790.[19]吴桂熙.活血通脉汤治疗下肢深静脉血栓45例[J].云南中医中药杂志,2009,30(6):27. [20]蒋晓伟.桃红四物汤预防人工膝关节置换术后DVT的临床观察[J].吉林医学,2010,31(16):2421-2422.[21]马拥军,蔡伟.桃红四物汤加减配合西药预防髋关节周围骨折术后深静脉血栓形成22例[J].中医研究,2011,24(7):43-44.[22]邱贵兴,杨庆铭,余楠生,等.低分子肝素预防髋、膝关节手术后下肢深静脉血栓形成的多中心研究[J].中华骨科杂志,2006,26(12): 819-822. [23]王强,盛伟斌,吴兵,等.低分子肝素预防老年髋关节周围骨折术后下肢深静脉血栓的研究[J].现代中西医结合杂志,2009,18(20): 2367-2369. [24]李明,王志萍.术前应用低分子肝素对老年人工髋关节置换术后下肢深静脉血栓的预防作用[J].徐州医学院学报,2012,32(3): 158-161. [25]杨帆,张黎军,蒋小波.达比加群220 mg和150 mg对膝、髋关节置换术后静脉血栓预防的疗效及安全性评价[J].中华临床医师杂志(电子版),2013,7(1):226-232.[26]李虎,王健,肖军,等.比较磺达肝癸钠与依诺肝素预防骨科大手术后静脉血栓栓塞症疗效与安全性的Meta分析[J]. 南方医科大学学报,2013,3(3):370-375. [27]杨帆,张黎军,蒋小波,等.达比加群220 mg与依诺肝素对膝、髋关节置换术后静脉血栓预防的职效及安全性比较评价[J].疑难病杂志,2013,12(3):205-209.[28]高乐才,吴文元,魏金栋,等.利伐沙班与低分子肝素对髋、膝关节置换术后隐性失血影响的对比观察[J].现代中西医结合杂志, 2013,22(7):721-722.[29]张建方,金国强,姚航军,等.补阳还五汤加减预防髋关节置换术后深静脉血栓形成的临床研究[J].中医正骨,2013,25(2):19-21,24. [30]阮朝阳,曾强华,朱群威.丹参注射液预防全髋关节置换术后静脉血栓栓塞[J].中医正骨,2013,25(1):30-32.[31]戴号,王凌椿,翟伟韬.加叶桃核承气汤预防人工全髋关节置换术术后下肢深静脉血栓的效果评价[J].四川中医,2012,30(10): 68-70.[32]韩庆松.活血通栓饮预防髋关节置换术后下肢深静脉血栓临床观察[J].新中医,2012,44(4):52-53.[33]魏国俊,董林,王久夏,等.佛手通瘀汤预防人工髋关节置换术后下肢深静脉血栓形成的疗效研究[J].中国中医骨伤科杂志,2011, 19(6):15-17.[34]蒋雷鸣,樊效鸿.身痛逐淤汤熏洗对全髋关节置换术后DVT防治的疗效分析[J].中医临床研究,2012,4(23):23-24.[35]李冬春,王勇.消栓饮预防人工髋关节置换术后深静脉血栓形成的临床观察[J].中国医疗前沿,2012,7(4):41-42 |